Cargando…
An Open-Label Pilot Study Testing the Feasibility of Assessing Total Symptom Burden in Trials of Cannabinoid Medications in Palliative Care
Background: There is considerable interest in the use of cannabinoids for symptom control in palliative care, but there is little high-quality evidence to guide clinical practice. Objectives: Assess the feasibility of using global symptom burden measures to assess response to medicinal cannabis, to...
Autores principales: | Good, Phillip D., Greer, Ristan M., Huggett, Georgina E., Hardy, Janet R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232640/ https://www.ncbi.nlm.nih.gov/pubmed/31800354 http://dx.doi.org/10.1089/jpm.2019.0540 |
Ejemplares similares
-
Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo controlled, randomised clinical trial of efficacy and safety of cannabidiol (CBD)
por: Good, Phillip, et al.
Publicado: (2019) -
Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of efficacy and safety of 1:1 delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD)
por: Hardy, Janet, et al.
Publicado: (2020) -
Exploring potential anti-inflammatory effects of medicinal cannabis
por: Gurgenci, Taylan, et al.
Publicado: (2023) -
Rates and Predictors of Professional Interpreting Provision for Patients With Limited English Proficiency in the Emergency Department and Inpatient Ward
por: Ryan, Jennifer, et al.
Publicado: (2017) -
Using a qualitative sub-study to inform the design and delivery of randomised controlled trials on medicinal cannabis for symptom relief in patients with advanced cancer
por: Olson, Rebecca E., et al.
Publicado: (2022)